Neutrophils also modulate CD8+ T cell responses in metastatic liver cancer (MLC) and exhibit heterogeneous N1/N2 phenotypes regulated by TGF-β and IGF1, influencing pro- or anti-tumor effects (72, 73). This evidence concerns the gene CD8A and neoplasm.